Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05142696
What this trial is testing

[177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Novartis Pharmaceuticals 55
Not applicableStudy completedNCT00997230
What this trial is testing

Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m

Who this might be right for
Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca 4,243
Not applicableStudy completedNCT00450281
What this trial is testing

S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 981
Large-scale testing (Phase 3)Study completedNCT01450761
What this trial is testing

Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone

Who this might be right for
Small Cell Lung Carcinoma
Bristol-Myers Squibb 1,351
Testing effectiveness (Phase 2)Study completedNCT01250119
What this trial is testing

Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 688
Not applicableUnknownNCT02603627
What this trial is testing

Prevalence of COPD in Our Lung Cancer Population, Compared to Controls

Who this might be right for
COPDLung CancerSmoking
Guy's and St Thomas' NHS Foundation Trust 200
Not applicableStudy completedNCT03212560
What this trial is testing

Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients

Who this might be right for
Hematologic Malignancies
Gazi University 30
Testing effectiveness (Phase 2)Study completedNCT00955175
What this trial is testing

Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09

Who this might be right for
Lung Cancer
Cancer Trials Ireland 60
Testing effectiveness (Phase 2)Ended earlyNCT01859741
What this trial is testing

A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum Therapy

Who this might be right for
Stage IV Small Cell Lung Cancer
OncoMed Pharmaceuticals, Inc. 172
Large-scale testing (Phase 3)Study completedNCT00533949
What this trial is testing

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Lung CancerRadiation Toxicity
Radiation Therapy Oncology Group 544
Large-scale testing (Phase 3)Study completedNCT02130557
What this trial is testing

Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Who this might be right for
Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
Pfizer 536
Testing effectiveness (Phase 2)Study completedNCT00003943
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer.

Who this might be right for
Carcinoma of Unknown PrimaryLung Cancer
Fox Chase Cancer Center 3
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT03999710
What this trial is testing

Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerLung CancerNsclc+2 more
Memorial Sloan Kettering Cancer Center 61
Not applicableLooking for participantsNCT07028489
What this trial is testing

Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
N-Power Medicine 130
Not applicableStudy completedNCT03007953
What this trial is testing

Palliative Care Interventions for Outpatients Newly Diagnosed With Lung Cancer: Phase II

Who this might be right for
Lung Cancer
VA Office of Research and Development 151
Not applicableUnknownNCT03568799
What this trial is testing

4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Who this might be right for
Lung CancerSolitary Pulmonary NoduleCigarette Smoking Behavior
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 30
Testing effectiveness (Phase 2)Ended earlyNCT04441138
What this trial is testing

Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC

Who this might be right for
Stage III Non-small-cell Lung Cancer
Rush University Medical Center 10
Not applicableStudy completedNCT01883986
What this trial is testing

Supportive Care for Patients Newly Diagnosed With Lung Cancer

Who this might be right for
Lung Cancer
VA Office of Research and Development 41
Testing effectiveness (Phase 2)Study completedNCT02448225
What this trial is testing

18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules

Who this might be right for
Lung CarcinomaSolitary Pulmonary NoduleCigarette Smoking Behavior
Vanderbilt-Ingram Cancer Center 46
Next Page